Abstract:In recent years, neurological and neurodegenerative disorders research has focused on altered molecular mechanisms in search of potential pharmacological targets, e.g., imbalances in mechanisms of response to oxidative stress, inflammation, apoptosis, autophagy, proliferation, differentiation, migration, and neuronal plasticity, which occur in less common neurological and neurodegenerative pathologies (Huntington disease, multiple sclerosis, fetal alcohol spectrum disorders, and Down syndrome). Here, we assess the effects of different catechins (particularly of epigalocatechin-3-gallate, EGCG) on these disorders, as well as their use in attenuating age-related cognitive decline in healthy individuals. Antioxidant and free radical scavenging properties of EGCG -due to their phenolic hydroxyl groups-, as well as its immunomodulatory, neuritogenic, and autophagic characteristics, makes this catechin a promising tool against neuroinflammation and microglia activation, common in these pathologies. Although EGCG promotes the inhibition of protein aggregation in experimental Huntington disease studies and improves the clinical severity in multiple sclerosis in animal models, its efficacy in humans remains controversial. EGCG may normalize DYRK1A (involved in neural plasticity) overproduction in Down syndrome, improving behavioral and neural phenotypes. In neurological pathologies caused by environmental agents, such as FASD, EGCG enhances antioxidant defense and regulates placental angiogenesis and neurodevelopmental processes. As demonstrated in animal models, catechins attenuate age-related cognitive decline, which results in improvements in long-term outcomes and working memory, reduction of hippocampal neuroinflammation, and enhancement of neuronal plasticity; however, further studies are needed. Catechins are valuable compounds for treating and preventing certain neurodegenerative and neurological diseases of genetic and environmental origin. However, the use of different doses of green tea extracts and EGCG makes it difficult to reach consistent conclusions for different populations.

Therapeutic potential of green tea catechins on the development of Parkinson's disease symptoms in a transgenic A53T mouse model

Distinct Effects of Tea Catechins on 6-Hydroxydopamine-induced Apoptosis in PC12 Cells

Neuroprotective effect of green tea extract (-)-epigallocatechin-3-gallate in a preformed fibril-induced mouse model of Parkinson's disease

Tea Polyphenols Alleviate Motor Impairments, Dopaminergic Neuronal Injury, and Cerebral Α-Synuclein Aggregation in MPTP-intoxicated Parkinsonian Monkeys.

EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson’s disease

Neuroprotective Effects and Mechanisms of Tea Bioactive Components in Neurodegenerative Diseases

Gardenin A treatment attenuates inflammatory markers, synuclein pathology and deficits in tyrosine hydroxylase expression and improves cognitive and motor function in A53T-α-syn mice

Dietary supplementation of a high-temperature-processed green tea extract attenuates cognitive impairment in PS2 and Tg2576 mice

Long-Term Green Tea Catechin Administration Prevents Spatial Learning And Memory Impairment In Senescence-Accelerated Mouse Prone-8 Mice By Decreasing A Beta(1-42) Oligomers And Upregulating Synaptic Plasticity-Related Proteins In The Hippocampus

Effects and Mechanisms of Tea on Parkinson’s Disease, Alzheimer’s Disease and Depression

Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson's disease

Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases

Dietary Intake of Α-Ketoglutarate Ameliorates Α-Synuclein Pathology in Mouse Models of Parkinson’s Disease

Effects of Green Tea Polyphenols on Dopamine Uptake and on Mpp+-Induced Dopamine Neuron Injury

Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson’s Disease: A Review

Green Tea Intake and Parkinson's Disease Progression: A Mendelian Randomization Study

Long-term Administration of Green Tea Catechins Prevents Age-Related Spatial Learning and Memory Decline in C57BL/6 J Mice by Regulating Hippocampal Cyclic Amp-Response Element Binding Protein Signaling Cascade

Therapeutic Effects of Catechins in Less Common Neurological and Neurodegenerative Disorders

Protective Effects of Epigallocatechin Gallate in MPTP-induced Mouse Model of Parkinson's Disease

Neurodegenerative diseases and catechins: (-)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress

Green Tea Suppresses Amyloid β Levels and Alleviates Cognitive Impairment by Inhibiting APP Cleavage and Preventing Neurotoxicity in 5XFAD Mice